Israel Englander’s PureTech Health PRTC Stock Holding History

Israel Englander’s Portfolio PRTC Stock Details PRTC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-59,525	Closed	-$883K	–	6298
2026 Q1	$883K	Buy	59,525 +44,090	+286%	+$765K	﹤0.01%	4472
2025 Q4	$266K	Sell	15,435 -2,406	-13%	-$41.3K	﹤0.01%	5331
2025 Q3	$328K	Sell	17,841 -6,016	-25%	-$106K	﹤0.01%	5299
2025 Q2	$419K	Sell	23,857 -21,054	-47%	-$371K	﹤0.01%	5013
2025 Q1	$860K	Sell	44,911 -353	-0.8%	-$6.45K	﹤0.01%	4470
2024 Q4	$823K	Buy	+45,264	New	+$948K	﹤0.01%	4358

Israel Englander's PRTC Position: Q2 2026 in Review

Israel Englander sold out of PureTech Health (PRTC) in Q2 2026, closing a stake of 59,525 shares — an estimated $883K sold.

Israel Englander first reported a position in PRTC in Q4 2024 and held it in 6 quarters. The position peaked at $883K in Q1 2026. 0 funds tracked by Wall St. Rank hold PRTC as of Q2 2026.

Israel Englander reported no remaining PureTech Health position as of Q2 2026 after selling out during the quarter.
Israel Englander sold 59,525 PureTech Health shares in Q2 2026, an estimated $883K.
Israel Englander first reported a position in PureTech Health in Q4 2024 and held it in 6 quarters.
Israel Englander's PureTech Health position peaked at $883K in Q1 2026.
0 funds tracked by Wall St. Rank held PureTech Health as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.